EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRPV1 Inhibits Ferroptosis and Mitophagy to Alleviate Heart Failure by Activating SFXN2

Pan Liu, Shiguang Wang, Liya Li, Ruihua Li, Minming Fan, Jingjing Kong, Bing Gao, Jing Wang, Ran Xia

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl37052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Pan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Anhui University of Chinese Medicine, Special Project of Xin'an Medical and Traditional Chinese Medicine Modernization Research Inst…. Hauptthemen laut MEDLINE: TRPV Cation Channels, Mitophagy, Heart Failure, Ferroptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Anhui Provincial Scientific Research Planning Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) continues to represent a significant global public health concern. Transient receptor potential cation channel subfamily V member 1 (TRPV1) is a calcium-permeable channel that has been linked to cardiac disease and function. However, its significance in HF and underlying processes is unknown. This study aims to determine the regulatory role of TRPV1 in mitochondrial autophagy in HF.

Methods

AC16 cardiomyocytes were exposed to angiotensin II (Ang II) to simulate pathological conditions, and changes in oxidative stress were assessed. Transverse aortic constriction (TAC) was used to create a pressure overload-induced HF mouse model, and cardiac-specific TRPV1 overexpression was achieved by Adeno-associated virus 9 (AAV9). RNA sequencing and bioinformatics analysis were performed to identify TRPV1-related mitochondrial genes. Finally, the effects of TRPV1 overexpression and sideroflexin 2 (SFXN2) knockdown on markers related to mitophagy and ferroptosis were analyzed.

Results

In vitro, TRPV1 overexpression drastically decreased intracellular Ca2+ levels, lessened oxidative stress, and reduced Ang II-induced cell death (p < 0.05). Bioinformatics analysis identified seven mitochondrial genes associated with TRPV1, among which SFXN2 showed a strong correlation with TRPV1 (p < 0.05). Overexpressing cardiac-specific TRPV1 in the TAC model led to improved cardiac function, higher fractional shortening and ejection fraction, and reduced levels of mitophagy markers (p < 0.05). Mechanistically, TRPV1 activated SFXN2, increasing glutathione peroxidase 4 (GPX4) expression and antioxidant capacity (glutathione (GSH), superoxide dismutase (SOD)) while decreasing malondialdehyde (MDA) and ferrous iron (Fe2+) levels (p < 0.05). These protective effects were removed by SFXN2 knockdown. Furthermore, the TRPV1-SFXN2 axis suppressed mitophagy by modulating the PTEN-induced kinase 1 (PINK1)-Parkin-sequestosome 1 (SQSTM1) axis.

Conclusion

Our results show that TRPV1 overexpression alleviates Ang II-induced myocardial injury in HF. This protective effect is mediated through SFXN2-dependent mitophagy and ferroptosis, highlighting TRPV1 as a potential therapeutic target for HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsMitophagyHeart FailureFerroptosisAnimalsMiceMyocytes, CardiacOxidative StressMaleMice, Inbred C57BLDisease Models, AnimalCell LineAngiotensin IICalcium

Stichwörter der Autor:innen

SFXN2TRPV1ferroptosisheart failuremitophagy

Substanzen

TRPV Cation ChannelsTRPV1 protein, mouseAngiotensin IICalcium

Autor:innen und Institutionen

  • Graduate School, Anhui University of Chinese Medicine, Special Project of Xin'an Medical and Traditional Chinese Medicine Modernization Research Institute of Great Health Research Institute, 230012 Hefei, Anhui, China.
  • Department of Cardiology, The First Affiliated Hospital of Anhui University of Chinese Medicine, 230031 Hefei, Anhui, China.
  • Zhongyi School, Anhui University of Chinese Medicine, Special Project of Xin'an Medical and Traditional Chinese Medicine Modernization Research Institute of Great Health Research Institute, 230012 Hefei, Anhui, China.

Förderung

  • National Key R&D Program of China
  • Anhui Provincial Scientific Research Planning Project

Zitieren

APA

Liu, P., Wang, S., Li, L., Li, R., Fan, M., Kong, J., Gao, B., Wang, J., & Xia, R. (2025). TRPV1 Inhibits Ferroptosis and Mitophagy to Alleviate Heart Failure by Activating SFXN2. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl37052

Vancouver

Liu P, Wang S, Li L, Li R, Fan M, Kong J, et al. TRPV1 Inhibits Ferroptosis and Mitophagy to Alleviate Heart Failure by Activating SFXN2. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl37052

BibTeX
@article{Liu2025,
  author = {Liu, Pan and Wang, Shiguang and Li, Liya and Li, Ruihua and Fan, Minming and Kong, Jingjing and Gao, Bing and Wang, Jing and Xia, Ran},
  title = {TRPV1 Inhibits Ferroptosis and Mitophagy to Alleviate Heart Failure by Activating SFXN2},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl37052}
}
Kostenlos starten →